COVID-19 National Diagnostic Research

National Diagnostic Research (NDR) is a premier clinical research site and contract research organization (CRO) based in Knoxville, Tennessee. The company specializes in conducting Phase I-IV clinical trials across a broad spectrum of therapeutic areas, with a significant focus on infectious diseases, metabolic disorders, and vaccines. During the COVID-19 pandemic, NDR emerged as a critical partner for major pharmaceutical companies, facilitating large-scale diagnostic and vaccine research. The organization is known for its high-enrollment capabilities and its ability to provide high-quality clinical data for regulatory submissions.